Detalhe da pesquisa
1.
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies.
Semin Cancer Biol
; 91: 27-34, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871633
2.
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association.
J Cutan Pathol
; 51(1): 7-10, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36636954
3.
Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.
Dermatology
; 240(2): 329-336, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008073
4.
Safety of omalizumab in chronic urticaria during pregnancy: a real-life study.
Clin Exp Dermatol
; 49(4): 344-347, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956096
5.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
J Eur Acad Dermatol Venereol
; 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38284131
6.
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
J Dtsch Dermatol Ges
; 22(1): 34-42, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926830
7.
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Cancer
; 129(15): 2331-2340, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162404
8.
Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years.
Exp Dermatol
; 32(6): 852-858, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856013
9.
The Limitation of Accessing Hospital Services Due to COVID-19 Pandemic: A Pilot Study of the Telephone Triage to Re-Organize the Access to a Center for Sexual Health in Northwest Italy.
Sex Transm Dis
; 50(9): 603-606, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728659
10.
Follicular colonization in melanocytic nevi and melanoma: A literature review.
J Cutan Pathol
; 50(8): 773-778, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820529
11.
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
J Eur Acad Dermatol Venereol
; 37(10): 1991-1998, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335879
12.
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
BMC Cancer
; 22(1): 610, 2022 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659273
13.
Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis.
Dermatol Ther
; 35(5): e15407, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218275
14.
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs.
Dermatol Ther
; 35(12): e15866, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175129
15.
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness?
Dermatol Ther
; 35(11): e15803, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062429
16.
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis.
Dermatol Ther
; 35(12): e15917, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214268
17.
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life study.
Dermatol Ther
; 35(10): e15670, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762118
18.
Risankizumab shows high efficacy and maintenance in improvement of response until week 52.
Dermatol Ther
; 35(5): e15378, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156278
19.
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study.
Dermatol Ther
; 35(6): e15492, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384181
20.
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy.
Acta Derm Venereol
; 102: adv00821, 2022 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065745